All In MedTech

Device Trial Radar · NCT06807099

WRAP North America

Prospective, Multicenter, Observational Study to Evaluate the Merit WRAPSODY® Cell Impermeable Endoprosthesis for Treatment of Stenosis or Occlusion Within the Dialysis Outflow Circuit (WRAP North America)

Last checked: Nov 20, 2026Latest source record: Aug 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Jul 31, 2025

Primary completion

Dec 2027

Study completion Jul 2030

Sponsor

Lead sponsor
Merit Medical Systems, Inc.Public (MMSI)
Sponsor type
Industry
First posted
Feb 4, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this observational study is to investigate the safety and efficacy of the WRAPSODY CIE in a real-world North American population. Participants treated with the WRAPSODY CIE device in accordance with the device instructions for use will be followed in accordance with standard of care up to 3-years post-procedure.

Conditions

  • Venous Stenosis
  • Venous Occlusion

Interventions

  • Merit WRAPSODY® Cell Impermeable Endoprosthesis (WRAPSODY CIE)Device

    Target Lesion treated with WRAPSODY CIE

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects with Target Lesion Primary Patency (TLPP) (Primary Effectiveness Endpoint)Time frame: 6 months
  2. Proportion of subjects without any localized or systemic safety events (Primary Safety Endpoint)Time frame: 30 days

Locations

16 sites in 2 countries. Site status is shown where the registry gives one.

  • Trinity Research Group

    Dothan, Alabama · Recruiting

  • AKDHC Phoenix Surgery Center

    Phoenix, Arizona · Recruiting

  • Apex Research of Riverside

    Riverside, California · Recruiting

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.